Zuanic & Associates LLC

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

This Cannabis REIT Offers 13%+ Yield, Safer Returns Than Fed-Backed Bonds

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

This Cannabis REIT Offers 13%+ Yield, Safer Returns Than Fed-Backed Bonds

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan

Zuanic & Associates LLC Recent News

With 200+ New Dispensaries And Four States Voting On Legalizing Cannabis, Could Market Expansion Squeeze Margins Further?

Pablo Zuanic, senior analyst at Z&A, examines key trends this quarter: dispensary saturation, price pressure, and margins amid the elections.

Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?

Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth in Germany.

Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground

Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.

M&A Frenzy And Deflation Post-Election: Which Companies Are Ready To Win Big In Florida's Cannabis Market

November's election could bring significant growth opportunities—or intensified competition for cannabis companies in the Florida market.

EXCLUSIVE: Cannabis Rescheduling Is Not Cure-All For Industry Problems: Experts Explain How Tax Tactics Could Hurt Marijuana Businesses In Long Run

Rescheduling is not a cure-all for industry issues. It may improve balance sheets and attract capital, but won't bring major players like Wells Fargo without full legalization.

LIFD's 5x Potential: Is This Psychoactive Hemp Stock The Next Big Speculative Buy?

LIFD is expected to drive market share gains, according to a recent report from Zuanic & Associates, the stock could see a 5x rise by 2025.

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Ltd. has shown resilience in its H1 2024 performance despite facing significant challenges according to research by Z&A.

Decibel Cannabis Reports 22% YoY Decrease In Q2 Net Revenue, Plans To Benefit With New Product Launches

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) reported on Wednesday its unaudited interim financial results for the second quarter ending June 30, 2024. "Decibel has shown good discipline in reducing our current liabilities by ~5mm this quarter," Benjamin Sze, Decibel's CEO, said. "Market share has been challenged but early indications from Qwest relaunch suggest we will regain market share in flower. A continued focus on execution and capital efficiency will serve as the platform for future growth." The company reported net revenue of CA$22.1 million ($16.1 million), down from CA$28.5 million in the prior year's period, representing a 22% year-over-year drop. Its first quarter report published this past April revealed a 16% year-over-year revenue drop to CA$21 million and an adjusted net loss of CA$3.5 million.